Lastly, improving pharmacokinetics will be essential for the next generation of drugs. Some of the drugs being developed are quickly metabolized or difficult to target to their desired brain region. A better understanding of the molecular and structural basis of how these drugs interact with GIRK channels and how they alter gating will be fundamentally important for providing new insights into the development of novel strategies that can be explored for future drug discovery.
